EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advances in HER2-Targeted Cancer Vaccines: From Immunological Basis to Next-Generation Therapeutic Strategies

Tingnuo Wang

BIO Web of Conferences · 2026 · 240 · 01029

DOI: 10.1051/bioconf/202624001029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BIO Web of Conferences, online erschienen am 24.06.2026. Verfasst von Tingnuo Wang. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HER2-positive breast cancer is aggressive and associated with poor prognosis worldwide. While passive immunotherapy using monoclonal antibodies is effective, resistance and recurrence remain major challenges. HER2-targeted cancer vaccines offer a promising strategy to induce durable, antigen-specific immune responses. This review summarizes the biological and immunological basis of HER2 targeting, including oncogenic signaling and tumor antigenicity, and outlines both passive and active immunotherapeutic approaches. It highlights advances in HER2 vaccines, particularly mRNA-based strategies, and emphasizes combination therapies with immune checkpoint inhibitors, HER2-targeted agents, chemotherapy, and radiotherapy to enhance antitumor immunity and overcome immune evasion. Despite progress, challenges such as low immunogenicity, HLA restriction, and an immunosuppressive tumor microenvironment limit clinical efficacy. Future directions include optimizing antigen design, expanding combination strategies, and leveraging artificial intelligence for personalized vaccine development. Overall, HER2-targeted vaccines represent a promising frontier in next-generation cancer immunotherapy.

Zitieren

APA

Wang, T. (2026). Advances in HER2-Targeted Cancer Vaccines: From Immunological Basis to Next-Generation Therapeutic Strategies. BIO Web of Conferences, 240, 01029. https://doi.org/10.1051/bioconf/202624001029

Vancouver

Wang T. Advances in HER2-Targeted Cancer Vaccines: From Immunological Basis to Next-Generation Therapeutic Strategies. BIO Web of Conferences. 2026;240:01029. doi:10.1051/bioconf/202624001029

BibTeX
@article{Wang2026,
  author = {Wang, Tingnuo},
  title = {Advances in HER2-Targeted Cancer Vaccines: From Immunological Basis to Next-Generation Therapeutic Strategies},
  journal = {BIO Web of Conferences},
  year = {2026},
  volume = {240},
  pages = {01029},
  doi = {10.1051/bioconf/202624001029}
}
Kostenlos starten →